Dr. Jacob D. Soumerai, MD
- Medicare services, 2024
- 1,231
- Medicare patients, 2024
- 286
- Part D claims, 2024
- 244
- Publications
- 44
- Clinical trials
- 3
- Practice address
- 55 Fruit Street, Boston, MA 02114
- Practice phone
- Call (617) 726-2000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Soumerai's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jacob D. Soumerai is a hematologist and oncologist in Boston, Massachusetts
Dr. Soumerai practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.
Dr. Soumerai's NPI, 1972897908, was assigned on June 7, 2011. Dr. Soumerai graduated from Tufts University School of Medicine in 2011. Dr. Soumerai holds Massachusetts license 257173.
- NPI
- 1972897908NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6204097611
- NPI enumeration date
- June 7, 2011
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (617) 726-2000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 41
- Medical school graduation
- 2011
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Jacob D. Soumerai practices at Massachusetts General Hospital in Boston, Massachusetts
Dr. Soumerai's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.
- Massachusetts General Hospital55 Fruit Street, Boston, MA 02114 · Suffolk CountyPhone(617) 726-2000
Source: Dmand AI Affiliation Data
Dr. Jacob D. Soumerai is affiliated with 8 sites of care and 2 medical groups
Dr. Soumerai's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Soumerai is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Hospital. Dmand AI also links Dr. Soumerai to 3 more hospitals, 2 group practices and clinics, 1 community health center and 1 medical group, each named with a free account. Dr. Soumerai's employer is on file too: a hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Jacob D. Soumerai's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Soumerai practices, 8 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Massachusetts General Hospital | Available with a free account |
| +7 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Mass General Brigham and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jacob D. Soumerai is one of 429 hematologists and oncologists in Massachusetts
Hematology and oncology is Dr. Soumerai's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Soumerai is licensed in Massachusetts.
Specialties and state licenses
- Hematology and oncology, MassachusettsPrimary
Hematologists and oncologists near Dr. Soumerai
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jacob D. Soumerai billed Medicare for 1,231 services in 2024
CMS data shows 1,231 Medicare services from Dr. Soumerai across 6 procedure codes in 2024, for 286 Medicare patients. Medicare paid $88,593 for them.
Dr. Soumerai's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 7372024: 7664%
- Other services
- 2023: 572024: 465716%
Where Dr. Soumerai's Medicare services took place, 2024
- In an office484%
- In a facility1,18396%
Dr. Soumerai compared with the Massachusetts median for hematologists and oncologists, 2024
- Dr. Soumerai
- Massachusetts median
- Medicare services
- 1,231vs 4952.5 times
- Medicare patients
- 286vs 20043% above
- Part D claims
- 156vs 151Close to median
Medians across 415 hematologists and oncologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. Soumerai's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Soumerai?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Soumerai and other hematologists and oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Jacob D. Soumerai treated 286 Medicare patients in 2024, average age 74
CMS counts 286 Medicare patients who saw Dr. Soumerai in 2024. The largest group is 65 to 74, with 126 patients. 68% of them have high cholesterol, and 64% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Soumerai's median patient age at 74, with 43% women.
Dr. Soumerai's Medicare patients by age, 2024
Dr. Soumerai's Medicare patients by sex, 2024
- Women12544%
- Men16156%
Chronic conditions among Dr. Soumerai's Medicare patients, 2024
- High cholesterol68%
- High blood pressure64%
- Arthritis34%
- Ischemic heart disease31%
- Anxiety26%
- Chronic kidney disease26%
- Mood disorders25%
- Depression23%
Share of Medicare patients with each condition. A patient can have several.
Dr. Soumerai's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women43%
- Men57%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Jacob D. Soumerai wrote 244 Medicare Part D claims in 2024
In 2024, Dr. Soumerai wrote 244 Medicare Part D claims for 59 patients. 59% of them were for generic drugs. CMS names the drug for 156 of them, across 7 drugs with 11 or more claims each, at $962,853 in total drug cost. In 2023, CMS named 45 claims across 3 drugs.
Dr. Soumerai's Part D claims by kind of drug, 2024
- Generic144 claims59%
- Brand-name and other100 claims41%
Dr. Soumerai's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Soumerai's Part D claims, 2024
- Antibiotics9%23 of 244 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 452024: 156247%
Drugs named by CMS: 7 in 2024, 3 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Jacob D. Soumerai offers telehealth to Medicare patients
Dr. Soumerai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Soumerai as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Jacob D. Soumerai has 44 publications on record
Dmand AI links 44 papers to Dr. Soumerai, published from 2013 to 2025. 2025 was the busiest year, with 7. The most frequent topics are Leukemia, Lymphocytic, Chronic, B-Cell, Antineoplastic Combined Chemotherapy Protocols and Rituximab. Dr. Soumerai has published most often in Leuk Lymphoma. Dr. Soumerai's most frequent co-authors are Jeremy S. Abramson, MD, Jeffrey A. Barnes, MD, PhD and Ephraim P. Hochberg, MD.
Dr. Soumerai's papers by year, 2016 to 2025
Topics Dr. Soumerai writes about most
- Leukemia, Lymphocytic, Chronic, B-Cell
- Antineoplastic Combined Chemotherapy Protocols
- Rituximab
- Agammaglobulinaemia Tyrosine Kinase
- Immunotherapy, Adoptive
- Piperidines
- Protein Kinase Inhibitors
- Bridged Bicyclo Compounds, Heterocyclic
Dr. Soumerai's most frequent co-authors
- Jeremy S. Abramson, MD18 shared papers
- Jeffrey A. Barnes, MD, PhD11 shared papers
- Ephraim P. Hochberg, MD11 shared papers
Recent publications by Dr. Soumerai
J Natl Compr Canc Netw
See who Dr. Soumerai researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Soumerai works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Jacob D. Soumerai has worked on 3 clinical trials
Dmand AI links Dr. Soumerai to 3 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, B-Cell and Lymphoma, B-Cell, Marginal Zone. Massachusetts General Hospital sponsors the most, 2.
Conditions in Dr. Soumerai's trials
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Follicular
Recent clinical trials with Dr. Soumerai
A Phase 2 Study of Acalabrutinib, Umbralisib, and Ublituximab (AU2) in Relapsed and Previously Untreated CLL Patients (opens in a new tab)
A Phase 2 Study of Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Jacob D. Soumerai received $283,701 in industry payments from 2018 to 2025
CMS Open Payments shows 65 general payments to Dr. Soumerai from 14 drug and device companies from 2018 to 2025. Grants make up the largest share, 70% of the total. Genentech, Inc. paid the most, $213,706.
General payments to Dr. Soumerai by program year, 2018 to 2025
General payments to Dr. Soumerai by kind, 2018 to 2025
- Grants$200,00070%
- Consulting fees$80,48228%
- Food and beverage$1,7521%
- Travel and lodging$1,0130%
- Compensation for serving as faculty or as a speaker for a medical education program$4540%
Companies that paid Dr. Soumerai the most, 2018 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Jacob D. Soumerai graduated from Tufts University School of Medicine
Dr. Soumerai graduated from Tufts University School of Medicine in 2011.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Jacob D. Soumerai's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jacob D. Soumerai
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jacob D. Soumerai's NPI number?
Dr. Jacob D. Soumerai's NPI number is 1972897908. It was assigned on June 7, 2011, and it is active in the NPI Registry.
What kind of doctor is Dr. Jacob D. Soumerai?
Dr. Jacob D. Soumerai is a hematologist and oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Jacob D. Soumerai practice?
Dr. Soumerai practices at 55 Fruit Street, Boston, MA 02114. Dr. Soumerai's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dmand AI also links Dr. Soumerai to 3 hospitals, 2 group practices and clinics, 1 community health center and 1 medical group.
What is Dr. Jacob D. Soumerai's office phone number?
The practice phone on file for Dr. Soumerai is (617) 726-2000.
What is Dr. Jacob D. Soumerai's medical license number?
Dr. Soumerai holds Massachusetts license 257173.
Which hospitals is Dr. Jacob D. Soumerai affiliated with?
Dr. Soumerai practices at Massachusetts General Hospital in Boston, Massachusetts. Dr. Soumerai is also affiliated with Brigham and Women's Hospital. Dmand AI links Dr. Soumerai to 3 more hospitals.
What medical group is Dr. Jacob D. Soumerai part of?
Dr. Soumerai is linked to Massachusetts General Hospital. Dmand AI links Dr. Soumerai to 1 more medical group.
Does Dr. Jacob D. Soumerai accept Medicare?
Yes. CMS data shows Dr. Soumerai billed Medicare for 1,231 services in 2024, and Dr. Soumerai accepts Medicare assignment.
Does Dr. Jacob D. Soumerai offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Soumerai as offering telehealth services.
How many Medicare patients does Dr. Jacob D. Soumerai see?
CMS counts 286 Medicare patients who saw Dr. Soumerai in 2024, with an average age of 74.
Show 7 more questionsShow fewer questions
What services does Dr. Jacob D. Soumerai bill to Medicare?
In 2024, Dr. Soumerai's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and hospital inpatient care (99233).
Where did Dr. Jacob D. Soumerai go to medical school?
Dr. Soumerai graduated from Tufts University School of Medicine in 2011.
What drugs does Dr. Jacob D. Soumerai prescribe most?
In 2024 Medicare Part D data, Dr. Soumerai's most prescribed drugs by claims were Brukinsa, Prednisone and Sulfamethoxazole-Trimethoprim.
Has Dr. Jacob D. Soumerai received payments from drug or device companies?
CMS Open Payments shows $283,701 in general payments to Dr. Soumerai from 14 companies from 2018 to 2025. The largest total came from Genentech, Inc.
How long has Dr. Jacob D. Soumerai been practicing?
Dr. Soumerai graduated from medical school in 2011, 15 years ago.
Does Dr. Jacob D. Soumerai do research?
Dmand AI links 44 publications to Dr. Soumerai, published from 2013 to 2025. Dr. Soumerai has worked on 3 clinical trials.
Who does Dr. Jacob D. Soumerai publish with?
Dr. Soumerai's most frequent co-authors are Jeremy S. Abramson, MD (18 shared papers), Jeffrey A. Barnes, MD, PhD (11 shared papers) and Ephraim P. Hochberg, MD (11 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card